← Browse by Condition
Medical Condition
metastatic solid tumors
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1, Phase 1, Phase 2, Phase 2
NCT05836324 Phase 1
Recruiting
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
Enrollment
408 pts
Location
United States, Denma...
Sponsor
Incyte Corporation
NCT07193511 Phase 1, Phase 2
Recruiting
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Enrollment
355 pts
Location
United States
Sponsor
Avenzo Therapeutics, Inc.
NCT07159126 Phase 1
Recruiting
A Study of DS3610a in Participants With Advanced Solid Tumor
Enrollment
70 pts
Location
Japan
Sponsor
Daiichi Sankyo
NCT06660654 Phase 2
Recruiting
A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)
Enrollment
200 pts
Location
United States, Belgi...
Sponsor
Daiichi Sankyo
NCT05853367 Phase 1
Recruiting
Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)
Enrollment
178 pts
Location
United States, Canad...
Sponsor
Merck Sharp & Dohme LLC